-
Founded in:
2008-09-16 -
Country:
China -
Address:
Northern Suburbs, Dongchuan District, Kunming City, Yunnan Province -
Tax NO.:
91530113678736353R -
Registered Funds:
10 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Artemisia scoparia |
Inhibit the inflammatory response process, reduce capillary permeability, and alleviate inflammatory exudation
More
Inhibit the inflammatory response process, reduce capillary permeability, and alleviate inflammatory exudation |
0 | ||
| Raw Aconite |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| Raw Aconitum |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| CARTHAMI FLOS |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| OLIBANUM GUM |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
8050-07-5 | 0 | |
| Gold Leaf |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| Black Bones |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| Riligustilide |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
89354-45-0 | 0 | |
| RADIX PSAMMOSILENES |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| Extract of Paris polyphylla |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| TYPHONII RHIZOMA |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| RADIX TODDALAE |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
0 | ||
| Borneol |
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains.
More
This product uses Artemisia scabrae produced in Dongchuan, Kunming, Yunnan as the main drug. Pharmacological experiments and clinical studies have shown that this product can inhibit the inflammatory response process, reduce capillary permeability, and reduce inflammatory exudation. It has obvious analgesic, anti-inflammatory and detumescent effects on rheumatism, traumatic injuries, and various strains. |
507-70-0 | 1 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Artemisia scoparia |
|
50g | 0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| HEMSLEYADIN |
No specific pharmacological information is provided
More
No specific pharmacological information is provided |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| HEMSLEYADIN |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| HEMSLEYADIN |
No specific pharmacological effects mentioned
More
No specific pharmacological effects mentioned |
0 |